PF-06648671
CAS No. 1587727-31-8
PF-06648671 ( PF6648671 )
Catalog No. M12266 CAS No. 1587727-31-8
PF-06648671 (PF6648671) is a novel oral γ-secretase modulator being developed for the treatment of Alzheimer's disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 896 | Get Quote |
|
50MG | 3222 | Get Quote |
|
100MG | 4410 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePF-06648671
-
NoteResearch use only, not for human use.
-
Brief DescriptionPF-06648671 (PF6648671) is a novel oral γ-secretase modulator being developed for the treatment of Alzheimer's disease.
-
DescriptionPF-06648671 (PF6648671) is a novel oral γ-secretase modulator being developed for the treatment of Alzheimer's disease.Alzheimer Disease Phase 1 Discontinued
-
SynonymsPF6648671
-
PathwayWnt/Notch/Hedgehog
-
Targetγ-secretase
-
Recptorγ-secretase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1587727-31-8
-
Formula Weight538.93
-
Molecular FormulaC25H23ClF4N4O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C(N2CCN1[C@H]([C@H]3O[C@@H](C4=CC(F)=C(Cl)C=C4C(F)(F)F)CC3)C)=CC=C(N5C=C(C)N=C5)C2=O
-
Chemical Name2H-Pyrido[1,2-a]pyrazine-1,6-dione, 2-[(1S)-1-[(2S,5R)-5-[4-chloro-5-fluoro-2-(trifluoromethyl)phenyl]tetrahydro-2-furanyl]ethyl]-3,4-dihydro-7-(4-methyl-1H-imidazol-1-yl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
BMS-708163
A potent, selective and orally bioavailable inhibitor of γ-secretase with Aβ40 IC50 of 3.0 nM.
-
LY-411575
A potent γ-secretase inhibitor that has an IC50 value of 119 pM for reduction of Aβ levels in APP-transfected cell lines.
-
Semagacestat
A potent γ-secretase inhibitor that inhibits β-amyloid Aβ42, Aβ38 and Aβ40 with IC50 of 10.9, 12 and 12.1 nM, respectively.